MedTrace Logo

Pulsed Short Wave Therapy In Cesarean Section

NCT03604068 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-07-27

No results posted yet for this study

Summary

This clinical study is designed to assesses the benefit of adding pulsed shortwave therapy to the postoperative pain and recovery protocol following Cesarean section. Pulsed shortwave therapy is a safe adjunct pain therapy for acute and chronic pain.

Conditions

  • Postoperative Pain

Interventions

DEVICE

RecoveryRx

A pulsed shortwave therapy medical device

DEVICE

Sham RecoveryRx

A sham pulsed shortwave therapy medical device

Sponsors & Collaborators

  • BioElectronics Corporation

    lead INDUSTRY

Principal Investigators

  • Moustafa Chaaban, MD · Haykal hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-12-01
Completion
2018-12-30
FDA Device
Yes

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03604068 on ClinicalTrials.gov